Summary
1 - METHOD OF ACTION
Etanercept (Enbrel®) is a biotherapy belonging to the anti-TNF alpha family. Contrary to the other anti-TNF alpha drugs which are monoclonal antibodies, etanercept is a fusion protein. The soluble P75 TNF alpha receptor is linked to the Fc portion of a human IgG1. Etanercept binds to the soluble TNF alpha receptor competitively, preventing it from binding to its target receptors.
×
N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!
Therapeutics in Dermatology, Fondation René Touraine © 2001-2014
